Posts by: Maria Verissimo, MSc

News

The anti-tumor effects of apigenin, a molecule that has been shown to inhibit the growth of a variety of human cancers, have been evaluated for the first time in malignant mesothelioma ... Read more

June 23, 2017

Researchers Identify CXCR4 as Weak Therapeutic Target for Pleural Mesothelioma

News

A new study reports that a protein formerly identified as a potential therapeutic target in pleural mesothelioma, CXCR4, might not be a relevant approach for the treatment of such patients. Based ... Read more

June 9, 2017

Researchers Aim to Improve Diagnosis of Malignant Pleural Mesothelioma

News

A study has tried to overcome the challenges in the diagnosis of patients with malignant pleural mesothelioma (MPM) through the detection of two biomarkers in pleural effusions and in peripheral blood ... Read more

June 5, 2017June 5, 2017

Mathematical Modeling May Help Determine Best Treatment Schedules, Mesothelioma Study Shows

News

French researchers have used mathematical modeling to select the best treatment schedule and dosing of Navelbine (vinorelbine) chemotherapy for mesothelioma and non-small cell lung cancer (NSCLC) patients. Their study, “Mathematical modelling ... Read more

June 1, 2017

Protein from Bullfrog May Have Therapeutic Potential for Mesothelioma Patients

News

Researchers found that a protein with anti-cancer activity, which is isolated from the bullfrog, may be a good treatment option for mesothelioma, including in standard-of-care chemotherapy-resistant cancers. The protein, sialic ... Read more

May 12, 2017

Study Identifies Blood Biomarkers for Diagnosing Early MPM

News

Two potential biomarkers have been identified for the diagnosis of early malignant pleural mesothelioma (MPM) in a study that compared the differences in microRNA (miRNA) expression between MPM patients and ... Read more